Literature DB >> 10562835

Stereotactic radiosurgery. VIII. The classification of postradiation reactions.

P N Plowman1.   

Abstract

Postradiation reactions in the CNS are well described and catalogued in the conventional radiotherapy literature; acute, subacute and late CNS reactions are recognized. Tumours predispose to these normal tissue reactions by the oedema and pressure epiphenomena that occur in their environs, and probably by other mechanisms associated with tissue breakdown. That late normal tissue reactions (particularly permanent late sequelae--universally referred to as 'necrosis') occur in the normal nervous system is in the complication list of every radiosurgery centre. This article, for the first time, places postradiosurgery observations within or without the existing classification of reactions, and draws attention to the fact that previous 'radiosurgery risk factor' papers in the literature may be wrong to pool different 'reactions' in the formulation of risk formulae for normal brain damage following single shot radiotherapy. Acute reactions occur in the same manner as described for conventional radiotherapy, being a transient swelling phenomenon that occurs 12-48 h after therapy; they are fully reversible and do not usually augur late problems; routine administration of short duration steroids around the time of radiosurgery may prevent or delay the clinical signs. Subacute reactions occur 3-10 months later (a later time than the subacute reactions following conventionally fractionated radiotherapy), and may prove fully or partially reversible, or progress to permanent sequelae; the difference between these and late sequelae (which tend to be permanent themselves) then becomes blurred. That tumour swelling occurs in the subacute phase and is associated with oedema in the surrounding normal brain is an interesting observation (occurring in extra- and intra axial slow-growing tumours); it denotes tumour damage and has not been encountered in the conventionally-fractionated radiotherapy literature. Tumour shrinkage occurs later, with subsidence of the surrounding oedema, and this phenomenon may therefore be regarded (paradoxically) as a good prognostic sign, a point about which the referring clinician should be made aware. Similarly, contrast enhancement in the tumour perimeter at this time reflects a host reactive response and not tumour activity. Persistent clinical neurological signs and MRI changes (best seen on the T2 weighted sequences) beyond 2 years, indicate late damage or reaction. Usually, this represents scarring or coagulative necrosis without mass effect, but if there is a low signal area with mass effect and considerable surrounding oedema, liquefactive necrosis has occurred and (as in the brachytherapy literature) surgical decompression is very occasionally needed.

Entities:  

Mesh:

Year:  1999        PMID: 10562835     DOI: 10.1080/02688699943655

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  14 in total

1.  Tumefactive cysts: a delayed complication following radiosurgery for cerebral arterial venous malformations.

Authors:  Whitney B Edmister; John I Lane; Julie R Gilbertson; Robert D Brown; Bruce E Pollock
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

2.  Local control and overall survival for adjuvant stereotactic radiosurgery in patients with residual or recurrent disease.

Authors:  Tavish Nanda; Andrew Yaeh; Cheng-Chia Wu; Ashish Jani; Shumaila Saad; Yasir H Qureshi; Keith A Cauley; Jeraldine Lesser; Simon K Cheng; Steven R Isaacson; Michael B Sisti; Jeffrey N Bruce; Guy M McKhann; Sameer A Sheth; Andrew B Lassman; Tony J C Wang
Journal:  J Neurooncol       Date:  2017-11-23       Impact factor: 4.130

3.  Peritumoral and intratumoral hemorrhage after stereotactic radiosurgery for renal cell carcinoma metastasis to the brain.

Authors:  Fotios Kalfas; Nello Ronchini; Tomasz Tadeusz Godowicz; Paolo Cavazzani; Paolo Severi
Journal:  J Radiosurg SBRT       Date:  2011

4.  Neurovascular radiosurgery.

Authors:  M Söderman; W Y Guo; B Karlsson; D M Pelz; E Ulfarsson; T Andersson
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

5.  Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme.

Authors:  Yan Li; Janine M Lupo; Mei-Yin Polley; Jason C Crane; Wei Bian; Soonmee Cha; Susan Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2011-02-04       Impact factor: 12.300

6.  The developing role for intensity-modulated radiation therapy (IMRT) in the non-surgical treatment of brain metastases.

Authors:  A A Edwards; E Keggin; P N Plowman
Journal:  Br J Radiol       Date:  2009-12-17       Impact factor: 3.039

Review 7.  Gamma knife radiosurgery for essential tremor: a case report and review of the literature.

Authors:  Ameer L Elaimy; John J Demakas; Benjamin J Arthurs; Barton S Cooke; Robert K Fairbanks; Wayne T Lamoreaux; Alexander R Mackay; David R Greeley; Christopher M Lee
Journal:  World J Surg Oncol       Date:  2010-03-22       Impact factor: 2.754

8.  Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging.

Authors:  Christopher M McPherson; Ronald E Warnick
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

9.  Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence.

Authors:  Friso W A Hoefnagels; Frank J Lagerwaard; Esther Sanchez; Cornelis J A Haasbeek; Dirk L Knol; Ben J Slotman; W Peter Vandertop
Journal:  J Neurol       Date:  2009-03-10       Impact factor: 4.849

10.  Therapeutic effects of Holmium-166 chitosan complex in rat brain tumor model.

Authors:  Ryoong Huh; Yong Sook Park; Jong Doo Lee; Young Sun Chung; Yong Gou Park; Sang Sup Chung; Jin Woo Chang
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.